This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists changes to authorisations most relevant to vets.
Changes to authorisations most relevant to vets
The changes to authorisations most relevant to vets can be found below. Each product is listed, along with the authorisation holder, distribution category and details of which Summary of Product Characteristics (SPC) sections have been revised/changed.
Changes to the SPC, labels and leaflets may change how the medicines should be used. Details can be found on the VMD’s Product Information Database (PID) here.
Due to ongoing assessments, there may be a delay between the point at which a new change is authorised and the updated SPC being available on the PID. There may also be a delay between the point at which any SPC changes are authorised and implementation in the product literature. Unless you have been advised otherwise, the labelling instructions on the pack which is dispensed should be followed.
Prascend 1 mg Tablets for Horses
Boehringer Ingelheim Animal Health UK Ltd GB & NI POM-V
Section 3.6: Rare: Inappetence; anorexia; lethargy, Central nervous system disorder (e.g., depression and ataxia), diarrhoea, colic.
Very rare: sweating (sudation).